Catalyst Pharmaceuticals
CPRX
#3935
Rank
S$3.21 B
Marketcap
$27.08
Share price
-2.62%
Change (1 day)
62.65%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2024 (TTM): S$0.12 B

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings (TTM) are S$0.12 B. In 2023 the company made an earning of S$0.12 B a decrease over its 2022 earnings that were of S$0.13 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.12 B1.27%
2023 S$0.12 B-9.75%
2022 S$0.13 B98.83%
2021 S$68.6 M25.73%
2020 S$54.56 M25.38%
2019 S$43.51 M-198.25%
2018 -S$44.3 M84.68%
2017 -S$23.99 M1.88%
2016 -S$23.55 M-10.68%
2015 -S$26.36 M30.46%
2014 -S$20.21 M27.6%
2013 -S$15.84 M198.17%
2012 -S$5.31 M-36.22%
2011 -S$8.33 M59.52%
2010 -S$5.22 M-44.68%
2009 -S$9.44 M-31.45%
2008 -S$13.77 M155.21%
2007 -S$5.4 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$0.38 B 219.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$81.04 M-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
S$26.40 B 21,567.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.36 B-390.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$1.58 B-1,395.38%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.47 B 6,856.81%๐Ÿ‡บ๐Ÿ‡ธ USA